DE:HQ1 / Oruka Therapeutics, Inc. - Participation institutionnelle - Vendeurs

Oruka Therapeutics, Inc.
DE ˙ DB
Participation institutionnelle et des fonds - Vendeurs

Cette page montre les institutions, les fonds et les principaux actionnaires qui ont réduit leurs avoirs ou fermé leurs positions lors de leur dernière période de déclaration. Les lignes rouges indiquent les positions fermées. Cliquez sur l'icône du lien pour voir l'historique complet des transactions.

Passez au niveau supérieurpour débloquer des données premium.

Date de dépôt Source Investisseur Type Prix moyen
(Est)
Actions Δ Actions
(%)
Valeur déclarée
(1000 $)
Δ Valeur
(%)
Allocation de portefeuille
(%)
2025-08-14 13F Susquehanna International Group, Llp 33 962 -90,30 381 -89,42
2025-08-14 13F Price T Rowe Associates Inc /md/ 410 881 -0,18 5 0,00
2025-05-15 13F Paradigm Biocapital Advisors LP 0 -100,00 0
2025-06-26 NP USMIX - Extended Market Index Fund 3 633 -2,10 38 -24,49
2025-08-14 13F Polar Capital Holdings Plc 975 000 -7,14 10 930 1,45
2025-06-18 NP REBYX - U.S. Small Cap Equity Fund Class Y Short -1 036 -8,96 -11 -33,33
2025-08-12 13F Jefferies Financial Group Inc. 64 991 -83,95 729 -82,48
2025-05-15 13F Perceptive Advisors Llc 0 -100,00 0 -100,00
2025-08-14 13F Goldman Sachs Group Inc 72 249 -70,41 810 -67,70
2025-08-27 13F/A Squarepoint Ops LLC 0 -100,00 0 -100,00
2025-05-15 13F Great Point Partners Llc 0 -100,00 0
2025-08-15 13F Morgan Stanley 208 328 -60,53 2 335 -56,88
2025-05-14 13F Ensign Peak Advisors, Inc 0 -100,00 0
2025-05-15 13F Driehaus Capital Management Llc 0 -100,00 0 -100,00
2025-08-14 13F Artia Global Partners LP 0 -100,00 0
2025-08-13 13F Kennedy Capital Management, Inc. 64 926 -1,25 728 7,86
2025-08-19 NP RIFBX - U.S. Small Cap Equity Fund 0 -100,00 0 -100,00
2025-08-26 NP PRHSX - T. Rowe Price Health Sciences Fund, Inc. This fund is a listed as child fund of Price T Rowe Associates Inc /md/ and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 257 030 -6,29 2 881 2,38
2025-05-15 13F Janus Henderson Group Plc 0 -100,00 0
2025-08-14 13F Wellington Management Group Llp 0 -100,00 0
2025-08-14 13F Boothbay Fund Management, Llc 19 003 -64,56 213 -61,27
2025-08-28 NP LYFCX - AlphaCentric LifeSci Healthcare Fund Class C 4 023 -18,13 45 -10,00
2025-05-15 13F Adage Capital Partners Gp, L.l.c. 0 -100,00 0 -100,00
2025-08-14 13F Occudo Quantitative Strategies Lp 0 -100,00 0
2025-08-13 13F ExodusPoint Capital Management, LP 0 -100,00 0
2025-08-14 13F Allostery Investments LP 0 -100,00 0
2025-08-13 13F OMERS ADMINISTRATION Corp 0 -100,00 0
2025-05-15 13F 683 Capital Management, LLC 0 -100,00 0
2025-05-15 13F Aster Capital Management (DIFC) Ltd 0 -100,00 0
2025-08-14 13F Hrt Financial Lp 0 -100,00 0
2025-07-28 NP BIB - ProShares Ultra Nasdaq Biotechnology 1 377 -9,05 15 0,00
2025-03-28 NP DFAT - Dimensional U.S. Targeted Value ETF 0 -100,00 0 -100,00
2025-08-14 13F Point72 Asset Management, L.P. 330 000 -3,62 3 699 5,29
2025-08-14 13F Man Group plc 0 -100,00 0
2025-08-14 13F Millennium Management Llc 12 326 -77,23 138 -75,14
2025-04-28 NP John Hancock Funds II - Health Sciences Fund Class NAV 4 677 -43,62 47 -73,89
2025-08-14 13F Qube Research & Technologies Ltd 0 -100,00 0
2025-08-14 13F Ikarian Capital, LLC 68 574 -60,81 769 -57,21
2025-08-13 13F Renaissance Technologies Llc 13 900 -61,17 156 -57,77
2025-07-31 13F Quest Partners LLC 16 064 -1,66 180 7,78
2025-08-12 13F Coldstream Capital Management Inc 0 -100,00 0
2025-08-14 13F Redmile Group, LLC 0 -100,00 0
2025-07-24 NP FSKAX - Fidelity Total Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 58 135 -2,47 637 5,29
2025-08-14 13F Braidwell Lp 1 524 842 -3,03 17 093 5,95
2025-05-14 13F Jane Street Group, Llc 0 -100,00 0
2025-08-14 13F Group One Trading, L.p. 0 -100,00 0 -100,00
2025-07-29 13F Cannon Global Investment Management, LLC 0 -100,00 0
Other Listings
US:ORKA 15,40 $US
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista